Benzonatate and Brilinta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Benzonatate (benzonatate) and Brilinta (ticagrelor). Common drug interactions include full blood count decreased among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Benzonatate and Brilinta. It is created by eHealthMe based on reports of 62 people who take the same drugs from the FDA, and is updated regularly.

What is Benzonatate?

Benzonatate has active ingredients of benzonatate. It is often used in cough. eHealthMe is studying from 17,274 Benzonatate users. Check the latest studies of Benzonatate.

What is Brilinta?

Brilinta has active ingredients of ticagrelor. It is often used in stent. eHealthMe is studying from 22,469 Brilinta users. Check the latest studies of Brilinta.

On Aug, 11, 2026

62 people who take Benzonatate and Brilinta together, and have interactions are studied.

Benzonatate and Brilinta drug interactions.

What are the common drug interactions of Benzonatate and Brilinta, by gender? *:

female:

Full blood count decreased
Gastric cancer (stomach cancer)
Hypersomnia (excessive daytime sleepiness (eds))
Hypoxia (low oxygen in tissues)
Incoherent (talking in a confused and unclear way)
Leukocytosis (increased white blood cells)
Malaise (a feeling of general discomfort or uneasiness)
Memory impairment
Nausea (feeling of having an urge to vomit)
Neoplasm malignant (cancer tumour)

male:

Chronic kidney disease
Diarrhoea
Gait disturbance
Osteonecrosis (death of bone)
Osteoporosis (bones weak and more likely to break)
Pain
Abdominal discomfort
Anaemia (lack of blood)
Bk virus infection
Bone pain

What are the common drug interactions of Benzonatate and Brilinta, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Chronic kidney disease
Anaemia (lack of blood)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Asthenia (weakness)
Bone density decreased
Decreased activity
Depression
Emotional distress
Gait disturbance

50-59:

Bk virus infection
Hepatic failure (liver failure)
Pancreatic carcinoma (pancreatic cancer)
Pneumonia fungal
Abdominal pain upper
Acute myocardial infarction (acute heart attack)
Chronic kidney disease
Colon cancer
Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)

60+:

Chronic kidney disease
Dyspnoea (difficult or laboured respiration)
Cardiomyopathy (weakening of the heart muscle)
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Coronary artery thrombosis (clot formation in coronary artery)
Death
Diastolic dysfunction
Erythema (redness of the skin)
Fluid retention (an abnormal accumulation of fluid in the blood)
Headache (pain in head)

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 20 people, 32.26%
High Blood Pressure: 16 people, 25.81%
High Blood Cholesterol: 15 people, 24.19%
Pain: 12 people, 19.35%
Cardiac Disorder: 10 people, 16.13%
Infection: 7 people, 11.29%
Nausea (feeling of having an urge to vomit): 7 people, 11.29%
Chest Pain: 6 people, 9.68%
Neuralgia (pain in one or more nerves): 6 people, 9.68%
Fluid Retention (an abnormal accumulation of fluid in the blood): 6 people, 9.68%

* Approximation only. Some reports may have incomplete information.

Do you take Benzonatate and Brilinta?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously